T
49.87
1.43 (2.95%)
| Penutupan Terdahulu | 48.44 |
| Buka | 49.71 |
| Jumlah Dagangan | 746,678 |
| Purata Dagangan (3B) | 2,164,449 |
| Modal Pasaran | 5,424,224,256 |
| Harga / Jualan (P/S) | 302.64 |
| Harga / Buku (P/B) | 18.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Mar 2026 |
| EPS Cair (TTM) | -1.08 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.38% |
| Nisbah Semasa (MRQ) | 30.89 |
| Aliran Tunai Operasi (OCF TTM) | -71.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -44.95 M |
| Pulangan Atas Aset (ROA TTM) | -22.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -32.12% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Terns Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.50 |
|
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.28% |
| % Dimiliki oleh Institusi | 100.24% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Capitolis Liquid Global Markets Llc | 31 Dec 2025 | 3,045,200 |
| Holocene Advisors, Lp | 31 Dec 2025 | 2,775,493 |
| Lord, Abbett & Co. Llc | 31 Dec 2025 | 2,712,399 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BURROUGHS AMY L. | - | 46.07 | -14,583 | -671,839 |
| Jumlah Keseluruhan Kuantiti Bersih | -14,583 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -671,839 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 46.07 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BURROUGHS AMY L. | Pegawai | 16 Mar 2026 | Jual automatik (-) | 14,583 | 46.07 | 671,839 |
| BURROUGHS AMY L. | Pegawai | 16 Mar 2026 | Pelaksanaan pilihan | 14,583 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 02 Feb 2026 | Pengumuman | Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) |
| 07 Jan 2026 | Pengumuman | Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference |
| 02 Jan 2026 | Pengumuman | Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |